ArticleDiscover oncology2025
Improved brain tumor classification through DenseNet121 based transfer learning.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- PatchSight-ImmuneMap-LifeSpan as a unified AI framework for breast cancer diagnosis, immune profiling and prognostic prediction.Discover oncology · 2026Article
- An Efficient and Cohesive System for Enhanced Accuracy in Malignant Brain Tumor Diagnosis.Current medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Brain tumors have a big effect on a person's health by letting abnormal cells grow unchecked in the brain. This means that early and correct diagnosis is very important for effective treatment. Many of the current diagnostic methods are time-consuming, rely primarily on hand interpretation, and frequently yield unsatisfactory results. This work finds brain tumors in MRI data using DenseNet121 architecture with transfer learning. Model training made use of the Kaggle dataset. By preprocessing the stage, resizing the MRI pictures to minimize noise would help the model perform better. From one MRI scan, the proposed approach divides brain tissues into four groups: benign tumors, gliomas, meningiomas, and pituitary gland malignancies. The designed DenseNet121 architecture precisely classifies brain cancers. We assessed the models' performance in terms of accuracy, precision, recall, and F1-score. The suggested approach proved successful in the multi-class categorization of brain tumors since it attained an average accuracy improvement of 96.90%. Unlike previous diagnostic techniques, such as eye inspection and other machine learning models, the proposed DenseNet121-based approach is more accurate, takes less time to analyze, and requires less human input. Although the automated method ensures consistent and predictable results, human error sometimes causes more unpredictability in conventional methods. Based on MRI-based detection and transfer learning, this paper proposes an automated method for the classification of brain cancers. The method improves the precision and speed of brain tumor diagnosis, which benefits both MRI-based classification research and clinical use. The development of deep-learning models may even further improve tumor identification and prognosis prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.